The Scientist Staff
Infographic: How to Predict If a Species Is At Risk
Infographic: How to Predict If a Species Is At Risk
To calculate the likelihood that organisms will be harmed by climate change, researchers estimate their exposure, sensitivity, and ability to adapt to new conditions.
Infographic: How to Predict If a Species Is At Risk
Infographic: How to Predict If a Species Is At Risk

To calculate the likelihood that organisms will be harmed by climate change, researchers estimate their exposure, sensitivity, and ability to adapt to new conditions.

To calculate the likelihood that organisms will be harmed by climate change, researchers estimate their exposure, sensitivity, and ability to adapt to new conditions.

drug development, infographic
Infographic: Resurrecting Ancient Proteins
Infographic: Resurrecting Ancient Proteins
Amber Dance | Jul 1, 2018

Learn the basic steps researchers take when reconstructing proteins from the past and how these biomolecules can inform engineering projects.

Infographic: Ocean Mesocosms
Infographic: Ocean Mesocosms
Ruth Williams | Jul 1, 2018
How one research team studies the effects of ocean conditions on marine life
Infographic: Swimming After Eating
Infographic: Swimming After Eating
Ashley Yeager | Jul 1, 2018
How a meal affects minnows' positions in their schools
Infographic: Gassy Genes
Infographic: Gassy Genes
Ruth Williams | Jun 1, 2018

Soil scientists get bacteria to report on what their neighbors are up to.

Infographic: Packing DNA
Infographic: Packing DNA
Diana Kwon | Jun 1, 2018
Researchers watch the protein condensin in action.
New Treatments for Phenylketonuria Aim to Loosen Reins on Strict Diet
New Treatments for Phenylketonuria Aim to Loosen Reins on Strict Diet
Diana Kwon | May 29, 2018
Biotechs have developed enzyme replacements and genetically modified probiotics to treat patients with the rare metabolic disorder.
Immunotherapy More Effective in Men: Study
Immunotherapy More Effective in Men: Study
Kerry Grens | May 18, 2018
Women with metastatic cancer who were treated with a checkpoint inhibitor had a smaller benefit than did men.
FDA Approves Drug to Ease Symptoms of Opioid Withdrawal
FDA Approves Drug to Ease Symptoms of Opioid Withdrawal
Catherine Offord | May 17, 2018
Lucemyra is the first non-opioid drug to be approved in the U.S. specifically for this purpose.
Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data
Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data
Anna Azvolinsky | May 15, 2018
As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together real-world results.